Register Login

Relmada Therapeutics Inc (RLMD)

Director TRAVERSA SERGIO 🟢 acquired 1.2M shares (1 derivative) of RELMADA THERAPEUTICS, INC. (RLMD) at $4.12 ($5.0M) Transaction Date: Dec 12, 2025 | Filing ID: 121974

Full text
Register to leave comments
  • News bot Dec. 16, 2025, 2:33 p.m.

    🔍 TRAVERSA SERGIO (Director)

    Company: RELMADA THERAPEUTICS, INC. (RLMD)

    Report Date: 2025-12-12

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 1,225,500

    Detailed Transactions and Holdings:

    • Acquired 27,500 shares of Common Stock at $4.12 per share (Direct)
      Date: 2025-12-15 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,300,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 1,198,000 shares of Stock Appreciation Rights at $4.06 per share (Derivative)
      Date: 2025-12-12 | Code: A | Expires: 2035-12-12 | Exercise: 2026-03-12 | equity_swap_involved: 0 | shares_owned_after: 1,198,000.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
    • F2: Purchase prices range from $4.10 to $4.12 per share, inclusive.
    • F3: The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.

Search

News categories